In summary, we not only identified the critical roles of miR-221/222 as oncomiRs in breast cancer, but also characterized the molecular mechanisms through which miR-221/222 contributed to breast cancer progression and identified GAS5 as a direct target gene. This evidence concerns the gene GAS5 and breast cancer.